← Leaderboards
Hariharan Subramanian
Nanocytomics, Llc
$5,428,666
Attributed
$6,466,278
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,466,278 · 5
By mechanism
R44$4,841,114 · 3
R01$1,350,178 · 1
R43$274,986 · 1
Top collaborators
- Vadim Backman2 shared
- Ankit Bharat2 shared
- Lusik Surenovna Cherkezyan2 shared
Most similar at Nanocytomics, Llc
Same institution · by research overlap
- Lusik Surenovna Cherkezyan$137,493
Others in their field
Top investigators on “Cessation Of Life”
- David R. Weir · University Of Michigan At Ann Arbor$345,522,974
- John M Lachin · George Washington University$134,302,892
- David M Nathan · Massachusetts Institute Of Technology$127,791,564
- Judith S Hochman · New York University School Of Medicine$112,898,313
- Jeffrey H Samet · Boston University Medical Campus$91,739,367
- Judith S. Currier · University Of California Los Angeles$85,330,415
Research focus
Cessation Of LifeDiagnosisCostMicroscopyTechnologyNanoscaleCellsMalignant NeoplasmsCarcinogenesisScreeningValidationColonPancreasLungCancer EtiologyGeneticOpticsFutureNeoplasticProceduresSmall Business Innovation Research GrantBiophotonicsArchitectureMucous Membrane
Grant awards (12)
Translating buccal nanocytology for lung cancer screening into clinical practice$667,591
R01 · FY2025 · CA
Translating buccal nanocytology for lung cancer screening into clinical practice$682,587
R01 · FY2024 · CA
Screening for pancreatic cancer via nanocytology of duodenal cells$50,000
R43 · FY2018 · CA
NanoCytology to mitigate overdiagnosis of prostate cancer$782,124
R44 · FY2017 · CA · contact PI
Buccal Nanocytological Risk Stratification to Personalize Lung Cancer Screening$694,885
R44 · FY2017 · CA · contact PI
Buccal Nanocytological Risk Stratification to Personalize Lung Cancer Screening$769,969
R44 · FY2016 · CA · contact PI
NanoCytology to mitigate overdiagnosis of prostate cancer$713,412
R44 · FY2016 · CA · contact PI
Screening for pancreatic cancer via nanocytology of duodenal cells$224,986
R43 · FY2016 · CA
NanoCytology to mitigate overdiagnosis of prostate cancer$224,274
R44 · FY2015 · CA · contact PI
COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY$762,880
R44 · FY2014 · CA · contact PI
COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY$740,325
R44 · FY2013 · CA · contact PI
COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY$153,245
R44 · FY2012 · CA · contact PI